Dawn Francis is a Gastroenterology physician. OpenAlex indexes 167 publications with 1,758 citations (h-index 18); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Antihistamines in Eosinophilic Esophagitis
Sponsor: Mayo Clinic
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
85.5%Proton pump inhibitor72.6%Omeprazole68%Lansoprazole17%Esomeprazole Magnesium8%Pantoprazole Sodium7%Part D<11 patientsCorticosteroid7%Prednisone100%Part D<11 patients+ 1 more class in this area
Nervous system
8.4%SSRI5%Trazodone Hcl100%Part D<11 patientsTricyclic Antidepressant3.4%Amitriptyline Hcl100%Part D<11 patientsAnti-infectives
6.1%Macrolide Antimicrobial3.1%Azithromycin100%Part D<11 patientsSulfone3.1%Dapsone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Eosinophilic Esophagitis-Related Food Impaction: Distinct Demographics, Interventions, and Promising Predictive Models
Digestive Diseases and Sciences
2025 - Improving Employee Experience: Reducing Burnout, Decreasing Turnover and Building Well-being
Clinical Gastroenterology and Hepatology
2022 - Development of Achalasia in a Patient With Chronic Intestinal Pseudo-Obstruction
ACG Case Reports Journal
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”